The global vascular imaging market is projected to reach USD 4.54 billion by 2030 from USD 3.19 billion in 2025, growing at a CAGR of 7.3% during the forecast period. The growth in the vascular imaging market is fueled by the increasing burden of cardiovascular diseases, the need for early and precise diagnosis, and the expanding elderly population vulnerable to vascular conditions. Advances in technology, including 3D imaging, AI-powered diagnostics, and non-invasive techniques, are enhancing accuracy and efficiency, driving wider adoption. Furthermore, rising healthcare investments, improved infrastructure, and greater emphasis on preventive care, especially across emerging economies, are contributing significantly to the market’s expansion.
By product type, the systems & consoles segment is expected to register the highest CAGR during the forecast period.
By product type, the systems & consoles segment is expected to account for the highest CAGR in the vascular imaging market because they serve as the core platforms enabling advanced imaging modalities such as intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS). These systems provide high-resolution, real-time visualization critical for accurate diagnosis and guided interventions, driving demand in hospitals, ambulatory surgery centers, and specialty clinics. Continuous technological innovations—such as integration with AI, enhanced imaging software, and hybrid imaging capabilities—boost their clinical utility and adoption. Additionally, recurring revenue from compatible catheters and accessories further propels market growth, making systems and consoles a key investment focus for manufacturers.
By application, the vasculitis segment accounted for the highest CAGR of the market in 2024.
In the vascular imaging market, the vasculitis segment dominated the market due to its increasing prevalence and the critical need for accurate diagnosis and monitoring of inflammation in blood vessels. Advances in imaging technologies such as PET, MRI, and CT angiography have significantly improved the ability to detect and assess vasculitis at early stages, enabling timely and targeted treatment. Additionally, growing awareness among clinicians about the importance of vascular imaging in managing vasculitis, coupled with rising investment in advanced imaging modalities, is accelerating market growth. The chronic nature of vasculitis and its potential to cause severe complications further underscores the demand for sophisticated vascular imaging solutions, fueling robust expansion in this segment.
Asia Pacific is expected to register the highest growth rate in the market during the forecast period.
The Asia-Pacific region is expected to register the highest CAGR in the vascular imaging market, driven by the growing burden of cardiovascular diseases linked to an aging population, sedentary lifestyles, and the increasing prevalence of diabetes and hypertension. Significant investments in healthcare infrastructure, government programs promoting early diagnosis, and the rapid adoption of advanced imaging technologies are further fueling demand. Additionally, rising healthcare spending, the need for affordable imaging solutions, and the integration of AI-based tools across major economies such as China and India are propelling the region’s strong market growth.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (40%), Tier 2 (30%), and Tier 3 (30%)
• By Designation: C-level Executives (55%), Directors (27%), and Others (18%)
By Region: North America (35%), Europe (32%), Asia Pacific (25%), Latin America (6%), and the Middle East & Africa (2%)
The prominent players in this market are Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), Shenzhen Mindray Bio-Medical Electronics (China), FUJIFILM Corporation (Japan), Hologic Inc. (US), Samsung Electronics Co., Ltd. (South Korea), Shimadzu Corporation (Japan), United Imaging Healthcare (China), Konica Minolta (Japan), Neusoft Corporation (China), Bracco Imaging SPA (Italy), Bayer AG (Germany), Guerbet (France), Nipro Europe Group Companies (Belgium).
Research Coverage
The vascular imaging market is segmented by product type, application, end user, and region. Key factors influencing market growth include driving forces, restraints, opportunities, and challenges for stakeholders. The report also reviews the leading companies competing in the Vascular imaging market. A micro-level analysis can be conducted to examine trends, growth opportunities, and contributions to the market. Additionally, it highlights potential revenue growth opportunities across various market segments in five major regions.
Key Benefits of Buying the Report
The report is valuable for new entrants in the vascular imaging market as it provides comprehensive information about the market. This information is essential for understanding various investment opportunities. The report provides insights into both key and smaller players in the market, which can help create a solid basis for risk analysis when making investment decisions. It accurately segments the market by end users and regions, providing focused insights into specific market segments. Additionally, the report highlights key trends, challenges, growth drivers, and opportunities to support strategic decision-making through a thorough analysis.
The report provides insights into the following points:
• Key drivers (rising prevalence of cardiovascular diseases, minimally invasive and personalized interventions, technological advancements in vascular imaging technology, increasing investments, funds, and grants by public-private organizations), restraints (radiation exposure and contrast-related risks, unfavorable reimbursement scenario, high costs and resource requirements), opportunities (expanding economies offer high growth potential, increasing establishment of hospitals and diagnostic imaging centers, increasing adoption of teleradiology), and challenges (hospital budget cuts, increasing adoption of refurbished diagnostic imaging systems, dearth of trained professionals, image quality limitations because of patient and physiological motion) fueling the market growth of vascular imaging market.
• Product Development/Innovation: Emerging technologies in space, R&D, recent product launches & approvals in the vascular imaging market.
• Market Growth: In-depth insights into remunerative markets report analyze the vascular imaging market across varied geographies.
• Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the vascular imaging market
• Competitive Assessment: Detailed assessment of market share, service offerings, leading strategies of key players such as Philips Healthcare (Netherlands), GE Healthcare (US), Canon Medical Systems Corporation (Japan), Siemens Healthineers (Germany), and FUJIFILM Corporation (Japan), among others.
圖表清單 List of Tables & Figures
TABLE 1 VASCULAR IMAGING MARKET: INCLUSIONS AND EXCLUSIONS 27
TABLE 2 VASCULAR IMAGING MARKET: RISK ANALYSIS 41
TABLE 3 TECHNOLOGICAL ADVANCEMENTS IN VASCULAR IMAGING SYSTEMS 50
TABLE 4 VASCULAR IMAGING MARKET: UNMET NEEDS 56
TABLE 5 STRATEGIC MOVES BY KEY COMPANIES IN VASCULAR IMAGING MARKET 57
TABLE 6 VASCULAR IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS 59
TABLE 7 REGIONAL PRICING ANALYSIS OF KEY VASCULAR IMAGING MODALITIES,
2024 (USD) 65
TABLE 8 REGIONAL PRICING ANALYSIS OF KEY DIAGNOSTIC IMAGING MODALITIES,
2024 (USD) 66
TABLE 9 IMPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS, 2020–2024 (HS CODE 902212) 68
TABLE 10 EXPORT DATA FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212),
BY COUNTRY, 2020–2024 (USD THOUSAND) 69
TABLE 11 IMPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2020–2024 (USD THOUSAND) 70
TABLE 12 EXPORT DATA FOR ULTRASOUND SYSTEMS (HS CODE 901812), BY COUNTRY, 2020–2024 (USD THOUSAND) 71
TABLE 13 IMPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813), BY COUNTRY, 2020–2024 (USD THOUSAND) 72
TABLE 14 EXPORT DATA FOR MAGNETIC RESONANCE IMAGING SYSTEMS (HS CODE 901813), BY COUNTRY, 2020–2024 (USD THOUSAND) 73
TABLE 15 IMPORT DATA FOR X-RAY SYSTEMS (HS CODE 902214), BY COUNTRY,
2020–2024 (USD THOUSAND) 74
TABLE 16 EXPORT DATA FOR X-RAY SYSTEMS (HS CODE 902214), BY COUNTRY,
2020–2024 (USD THOUSAND) 75
TABLE 17 VASCULAR IMAGING MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 75
TABLE 18 CASE STUDY: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE 78
TABLE 19 US ADJUSTED RECIPROCAL TARIFF RATES 79
TABLE 20 CASE STUDY: AI-ASSISTED INTRAVASCULAR IMAGING FOR PRECISION ANGIOPLASTY 89
TABLE 21 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 90
TABLE 22 US FDA: MEDICAL DEVICE CLASSIFICATION 92
TABLE 23 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 93
TABLE 24 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 93
TABLE 25 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 94
TABLE 26 CHINA: CLASSIFICATION OF MEDICAL DEVICES 95
TABLE 27 INDUSTRY STANDARDS FOR VASCULAR IMAGING MARKET 97
TABLE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 98
TABLE 29 KEY BUYING CRITERIA, BY END USER 99
TABLE 30 VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 102
TABLE 31 VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY REGION,
2023–2030 (USD MILLION) 102
TABLE 32 VASCULAR IMAGING MARKET FOR ULTRASOUND, BY REGION,
2023–2030 (USD MILLION) 103
TABLE 33 VASCULAR IMAGING MARKET FOR DUPLEX ULTRASOUND, BY REGION,
2023–2030 (USD MILLION) 104
TABLE 34 VASCULAR IMAGING MARKET FOR DOPPLER ULTRASOUND, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 35 VASCULAR IMAGING MARKET FOR MRI, BY REGION, 2023–2030 (USD MILLION) 106
TABLE 36 VASCULAR IMAGING MARKET FOR X-RAY SYSTEMS, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 37 VASCULAR IMAGING MARKET FOR NUCLEAR IMAGING SYSTEMS, BY REGION, 2023–2030 (USD MILLION) 108
TABLE 38 VASCULAR IMAGING MARKET FOR CT SCANNERS, BY REGION,
2023–2030 (USD MILLION) 109
TABLE 39 VASCULAR IMAGING MARKET FOR OPTICAL COHERENCE TOMOGRAPHY,
BY REGION, 2023–2030 (USD MILLION) 109
TABLE 40 VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 41 VASCULAR IMAGING MARKET FOR ACCESSORIES & CONSUMABLES, BY REGION, 2023–2030 (USD MILLION) 111
TABLE 42 VASCULAR IMAGING MARKET FOR STRAIN IMAGING, BY REGION,
2023–2030 (USD MILLION) 112
TABLE 43 VASCULAR IMAGING MARKET FOR HIGH SPATIAL AND TEMPORAL RESOLUTION, BY REGION, 2023–2030 (USD MILLION) 112
TABLE 44 VASCULAR IMAGING MARKET FOR AUTOMATED VESSEL MORPHOLOGY ASSESSMENT, BY REGION, 2023–2030 (USD MILLION) 113
TABLE 45 VASCULAR IMAGING MARKET FOR STREAMLINED PROCEDURAL WORKFLOW,
BY REGION, 2023–2030 (USD MILLION) 114
TABLE 46 VASCULAR IMAGING MARKET FOR OTHER SOFTWARE & SERVICES, BY REGION, 2023–2030 (USD MILLION) 114
TABLE 47 VASCULAR IMAGING MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 116
TABLE 48 VASCULAR IMAGING MARKET FOR ATHEROSCLEROSIS, BY REGION,
2023–2030 (USD MILLION) 117
TABLE 49 VASCULAR IMAGING MARKET FOR ANEURYSM, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 50 VASCULAR IMAGING MARKET FOR VASCULITIS, BY REGION,
2023–2030 (USD MILLION) 118
TABLE 51 VASCULAR IMAGING MARKET FOR DEEP VEIN THROMBOSIS, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 52 VASCULAR IMAGING MARKET FOR ARTERIOVENOUS MALFORMATIONS & FISTULAS, BY REGION, 2023–2030 (USD MILLION) 120
TABLE 53 VASCULAR IMAGING MARKET FOR OTHER APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 120
TABLE 54 VASCULAR IMAGING MARKET, BY END USER, BY TYPE, 2023–2030 (USD MILLION) 122
TABLE 55 VASCULAR IMAGING MARKET FOR HOSPITALS, BY REGION,
2023–2030 (USD MILLION) 123
TABLE 56 VASCULAR IMAGING MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2023–2030 (USD MILLION) 124
TABLE 57 VASCULAR IMAGING MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION) 125
TABLE 58 VASCULAR IMAGING MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 126
TABLE 59 VASCULAR IMAGING MARKET, BY REGION, 2023–2030 (USD MILLION) 128
TABLE 60 NUMBER OF IMAGING TESTS IN UK, 2022–2025 128
TABLE 61 NUMBER OF MRI UNITS PER COUNTRY, 2022–2024 129
TABLE 62 NORTH AMERICA: MACROECONOMIC OUTLOOK 130
TABLE 63 NORTH AMERICA: VASCULAR IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 131
TABLE 64 NORTH AMERICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 131
TABLE 65 NORTH AMERICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES,
BY TYPE, 2023–2030 (USD MILLION) 131
TABLE 66 NORTH AMERICA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION) 132
TABLE 67 NORTH AMERICA: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES,
BY TYPE, 2023–2030 (USD MILLION) 132
TABLE 68 NORTH AMERICA: VASCULAR IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 133
TABLE 69 NORTH AMERICA: VASCULAR IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 133
TABLE 70 US: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 134
TABLE 71 US: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE,
2023–2030 (USD MILLION) 135
TABLE 72 US: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 135
TABLE 73 CANADA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 136
TABLE 74 CANADA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 136
TABLE 75 CANADA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 137
TABLE 76 EUROPE: MACROECONOMIC OUTLOOK 138
TABLE 77 EUROPE: VASCULAR IMAGING MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138
TABLE 78 EUROPE: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 139
TABLE 79 EUROPE: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 139
TABLE 80 EUROPE: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 139
TABLE 81 EUROPE: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 140
TABLE 82 EUROPE: VASCULAR IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 140
TABLE 83 EUROPE: VASCULAR IMAGING MARKET, BY END USER, 2023–2030 (USD MILLION) 141
TABLE 84 GERMANY: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 141
TABLE 85 GERMANY: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 86 GERMANY: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 142
TABLE 87 UK: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 143
TABLE 88 UK: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE,
2023–2030 (USD MILLION) 143
TABLE 89 UK: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 144
TABLE 90 FRANCE: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 144
TABLE 91 FRANCE: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 145
TABLE 92 FRANCE: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 145
TABLE 93 ITALY: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 146
TABLE 94 ITALY: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE,
2023–2030 (USD MILLION) 146
TABLE 95 ITALY: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 147
TABLE 96 SPAIN: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 147
TABLE 97 SPAIN: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 148
TABLE 98 SPAIN: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 148
TABLE 99 REST OF EUROPE: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 149
TABLE 100 REST OF EUROPE: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES,
BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 101 REST OF EUROPE: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 102 ASIA PACIFIC: MACROECONOMIC INDICATORS 151
TABLE 103 ASIA PACIFIC: VASCULAR IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 152
TABLE 104 ASIA PACIFIC: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 152
TABLE 105 ASIA PACIFIC: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 153
TABLE 106 ASIA PACIFIC: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 153
TABLE 107 ASIA PACIFIC: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 154
TABLE 108 ASIA PACIFIC: VASCULAR IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 154
TABLE 109 ASIA PACIFIC: VASCULAR IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 155
TABLE 110 JAPAN: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 156
TABLE 111 JAPAN: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 156
TABLE 112 JAPAN: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 156
TABLE 113 CHINA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 157
TABLE 114 CHINA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 158
TABLE 115 CHINA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 158
TABLE 116 INDIA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 159
TABLE 117 INDIA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 118 INDIA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 160
TABLE 119 SOUTH KOREA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 161
TABLE 120 SOUTH KOREA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES,
BY TYPE, 2023–2030 (USD MILLION) 161
TABLE 121 SOUTH KOREA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 162
TABLE 122 AUSTRALIA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 163
TABLE 123 AUSTRALIA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 163
TABLE 124 AUSTRALIA: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 163
TABLE 125 REST OF ASIA PACIFIC: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 164
TABLE 126 REST OF ASIA PACIFIC: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 127 REST OF ASIA PACIFIC: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION) 165
TABLE 128 LATIN AMERICA: MACROECONOMIC OUTLOOK 166
TABLE 129 LATIN AMERICA: VASCULAR IMAGING MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 167
TABLE 130 LATIN AMERICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 167
TABLE 131 LATIN AMERICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES,
BY TYPE, 2023–2030 (USD MILLION) 167
TABLE 132 LATIN AMERICA: ULTRASOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 133 LATIN AMERICA: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES,
BY TYPE, 2023–2030 (USD MILLION) 168
TABLE 134 LATIN AMERICA: VASCULAR IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 168
TABLE 135 LATIN AMERICA: VASCULAR IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 169
TABLE 136 BRAZIL: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 170
TABLE 137 BRAZIL: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 170
TABLE 138 BRAZIL: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 170
TABLE 139 MEXICO: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 171
TABLE 140 MEXICO: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 172
TABLE 141 MEXICO: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE,
2023–2030 (USD MILLION) 172
TABLE 142 REST OF LATIN AMERICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 173
TABLE 143 REST OF LATIN AMERICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 144 REST OF LATIN AMERICA: VASCULAR IMAGING MARKET FOR ULTRASOUND,
BY TYPE, 2023–2030 (USD MILLION) 173
TABLE 145 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 175
TABLE 146 MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY REGION,
2023–2030 (USD MILLION) 175
TABLE 147 MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 175
TABLE 148 MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES, BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 149 MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET FOR ULTRASOUND,
BY TYPE, 2023–2030 (USD MILLION) 176
TABLE 150 MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET FOR SOFTWARE & SERVICES, BY TYPE, 2023–2030 (USD MILLION) 177
TABLE 151 MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 177
TABLE 152 MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY END USER,
2023–2030 (USD MILLION) 178
TABLE 153 GCC COUNTRIES: VASCULAR IMAGING MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 178
TABLE 154 GCC COUNTRIES: VASCULAR IMAGING MARKET FOR SYSTEMS & CONSOLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 155 GCC COUNTRIES: VASCULAR IMAGING MARKET FOR ULTRASOUND, BY TYPE, 2023–2030 (USD MILLION) 179
TABLE 156 REST OF MIDDLE EAST & AFRICA: VASCULAR IMAGING MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 180
TABLE 157 REST OF MIDDLE EAST & AFRICA: SYSTEMS AND CONSOLES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180
TABLE 158 REST OF MIDDLE EAST & AFRICA: ULTRASOUND MARKET, BY TYPE,
2023–2030 (USD MILLION) 181
TABLE 159 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN VASCULAR IMAGING MARKET, JANUARY 2022–OCTOBER 2025 183
TABLE 160 VASCULAR IMAGING MARKET: DEGREE OF COMPETITION 185
TABLE 161 VASCULAR IMAGING MARKET: REGION FOOTPRINT 190
TABLE 162 VASCULAR IMAGING MARKET: PRODUCT TYPE FOOTPRINT (1/2) 191
TABLE 163 VASCULAR IMAGING MARKET: PRODUCT TYPE FOOTPRINT (2/2) 192
TABLE 164 VASCULAR IMAGING MARKET: APPLICATION FOOTPRINT 193
TABLE 165 VASCULAR IMAGING MARKET: END-USER FOOTPRINT 193
TABLE 166 VASCULAR IMAGING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 196
TABLE 167 VASCULAR IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION 197
TABLE 168 VASCULAR IMAGING MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT TYPE 197
TABLE 169 VASCULAR IMAGING MARKET: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025 198
TABLE 170 VASCULAR IMAGING MARKET: DEALS, JANUARY 2022–AUGUST 2025 199
TABLE 171 VASCULAR IMAGING MARKET: EXPANSIONS, JANUARY 2022–AUGUST 2025 199
TABLE 172 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 201
TABLE 173 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 202
TABLE 174 SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022–AUGUST 2025 203
TABLE 175 SIEMENS HEALTHINEERS AG: EXPANSIONS, JANUARY 2022–AUGUST 2025 205
TABLE 176 GE HEALTHCARE: COMPANY OVERVIEW 206
TABLE 177 GE HEALTHCARE: PRODUCTS OFFERED 207
TABLE 178 GE HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS,
JANUARY 2022–AUGUST 2025 209
TABLE 179 GE HEALTHCARE: DEALS, JANUARY 2022–AUGUST 2025 210
TABLE 180 GE HEALTHCARE: EXPANSIONS, JANUARY 2022–AUGUST 2025 212
TABLE 181 FUJIFILM CORPORATION: COMPANY OVERVIEW 213
TABLE 182 FUJIFILM CORPORATION: PRODUCTS OFFERED 214
TABLE 183 FUJIFILM CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025 216
TABLE 184 FUJIFILM CORPORATION: DEALS, JANUARY 2022–AUGUST 2025 216
TABLE 185 FUJIFILM CORPORATION: EXPANSIONS, JANUARY 2022–AUGUST 2025 217
TABLE 186 PHILIPS HEALTHCARE: COMPANY OVERVIEW 218
TABLE 187 PHILIPS HEALTHCARE: PRODUCTS OFFERED 219
TABLE 188 PHILIPS HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025 221
TABLE 189 PHILIPS HEALTHCARE: DEALS, JANUARY 2022–AUGUST 2025 221
TABLE 190 PHILIPS HEALTHCARE: EXPANSIONS, JANUARY 2022–AUGUST 2025 222
TABLE 191 SHIMADZU CORPORATION: COMPANY OVERVIEW 224
TABLE 192 SHIMADZU CORPORATION: PRODUCTS OFFERED 225
TABLE 193 SHIMADZU CORPORATION: DEALS, JANUARY 2022–AUGUST 2025 226
TABLE 194 UNITED IMAGING HEALTHCARE CO., LTD: COMPANY OVERVIEW 227
TABLE 195 UNITED IMAGING HEALTHCARE CO., LTD: PRODUCTS OFFERED 228
TABLE 196 UNITED IMAGING HEALTHCARE CO., LTD: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025 229
TABLE 197 UNITED IMAGING HEALTHCARE CO., LTD: DEALS, JANUARY 2022–AUGUST 2025 229
TABLE 198 UNITED IMAGING HEALTHCARE CO., LTD: EXPANSIONS,
JANUARY 2022–AUGUST 2025 230
TABLE 199 SAMSUNG HEALTHCARE: COMPANY OVERVIEW 231
TABLE 200 SAMSUNG HEALTHCARE: PRODUCTS OFFERED 232
TABLE 201 SAMSUNG HEALTHCARE: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025 233
TABLE 202 SAMSUNG HEALTHCARE: DEALS, JANUARY 2022–AUGUST 2025 233
TABLE 203 SAMSUNG HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2022–AUGUST 2025 233
TABLE 204 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW 234
TABLE 205 SHEZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 235
TABLE 206 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2025 235
TABLE 207 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: DEALS, JANUARY 2022–AUGUST 2025 236
TABLE 208 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW 237
TABLE 209 CANON MEDICAL SYSTEMS CORPORATION: PRODUCTS OFFERED 238
TABLE 210 CANON MEDICAL SYSTEMS CORPORATION: PRODUCT LAUNCHES, UPGRADES,
AND APPROVALS, JANUARY 2022–AUGUST 2025 239
TABLE 211 CANON MEDICAL SYSTEMS CORPORATION: DEALS, JANUARY 2022–AUGUST 2025 239
TABLE 212 CANON MEDICAL SYSTEMS CORPORATION: EXPANSIONS,
JANUARY 2022–AUGUST 2025 240
TABLE 213 KONICA MINOLTA, INC.: COMPANY OVERVIEW 241
TABLE 214 KONICA MINOLTA, INC.: PRODUCTS OFFERED 242
TABLE 215 NEUSOFT CORPORATION: COMPANY OVERVIEW 244
TABLE 216 NEUSOFT CORPORATION: PRODUCTS OFFERED 245
TABLE 217 NEUSOFT CORPORATION: PRODUCT LAUNCHES, UPGRADES, AND APPROVALS, JANUARY 2022–AUGUST 2024 246
TABLE 218 TERUMO CORPORATION: COMPANY OVERVIEW 247
TABLE 219 TERUMO CORPORATION: PRODUCTS OFFERED 248
TABLE 220 HOLOGIC, INC.: COMPANY OVERVIEW 249
TABLE 221 HOLOGIC, INC.: PRODUCTS OFFERED 250
TABLE 222 HOLOGIC, INC.: DEALS, JANUARY 2022–AUGUST 2025 251
TABLE 223 HOLOGIC, INC.: EXPANSIONS, JANUARY 2022–AUGUST 2025 251
TABLE 224 BRACCO IMAGING S.P.A.: COMPANY OVERVIEW 252
TABLE 225 BRACCO IMAGING S.P.A.: PRODUCTS OFFERED 252
TABLE 226 BRACCO IMAGING S.P.A.: DEALS, JANUARY 2022–AUGUST 2025 253
TABLE 227 BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2022–AUGUST 2025 253
TABLE 228 BAYER AG: COMPANY OVERVIEW 254
TABLE 229 BAYER AG: PRODUCTS OFFERED 255
TABLE 230 BAYER AG: DEALS, JANUARY 2022–AUGUST 2025 256
TABLE 231 BAYER AG: EXPANSION, JANUARY 2022–AUGUST 2025 256
TABLE 232 GUERBET: COMPANY OVERVIEW 257
TABLE 233 GUERBET: PRODUCTS OFFERED 258
TABLE 234 NIPRO EUROPE GROUP COMPANIES: COMPANY OVERVIEW 259
TABLE 235 NIPRO EUROPE GROUP COMPANIES: PRODUCTS OFFERED 259
TABLE 236 ACCUVEIN, INC.: COMPANY OVERVIEW 260
TABLE 237 CHISON MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW 261
TABLE 238 SONOSCAPE MEDICAL CORP.: COMPANY OVERVIEW 262
TABLE 239 PIUR IMAGING: COMPANY OVERVIEW 263
TABLE 240 ARINETA LTD: COMPANY OVERVIEW 263
TABLE 241 HEALCERION CO., LTD.: COMPANY OVERVIEW 264
TABLE 242 ECHONOUS INC.: COMPANY OVERVIEW 265
TABLE 243 BEIJING WEMED MEDICAL EQUIPMENT: COMPANY OVERVIEW 266
TABLE 244 CLARIUS: COMPANY OVERVIEW 267
TABLE 245 ESAOTE SPA: COMPANY OVERVIEW 268
FIGURE 1 VASCULAR IMAGING MARKET SEGMENTATION AND REGIONAL SCOPE 27
FIGURE 2 RESEARCH DESIGN 29
FIGURE 3 KEY SECONDARY SOURCES 30
FIGURE 4 PRIMARY SOURCES 32
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 33
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 34
FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 35
FIGURE 8 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 36
FIGURE 9 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 37
FIGURE 10 TOP-DOWN APPROACH 38
FIGURE 11 GLOBAL MARKET GROWTH PROJECTIONS 39
FIGURE 12 DATA TRIANGULATION METHODOLOGY 40
FIGURE 13 VASCULAR IMAGING MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 42
FIGURE 14 VASCULAR IMAGING MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 43
FIGURE 15 VASCULAR IMAGING MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 43
FIGURE 16 GROWING PREVALENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET 45
FIGURE 17 HOSPITALS SEGMENT AND US LED NORTH AMERICAN MARKET IN 2025 46
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 47
FIGURE 19 VASCULAR IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 48
FIGURE 20 VASCULAR IMAGING MARKET: PORTER’S FIVE FORCES 59
FIGURE 21 VASCULAR IMAGING MARKET: SUPPLY CHAIN ANALYSIS 62
FIGURE 22 VASCULAR IMAGING MARKET: VALUE CHAIN ANALYSIS 63
FIGURE 23 ECOSYSTEM ANALYSIS 64
FIGURE 24 IMPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212), 2020–2024 (USD THOUSAND) 67
FIGURE 25 EXPORT SCENARIO FOR COMPUTED TOMOGRAPHY SYSTEMS (HS CODE 902212), 2020–2024 (USD THOUSAND) 68
FIGURE 26 IMPORT SCENARIO FOR ULTRASOUND SYSTEMS (HS CODE 901812),
2020–2024 (USD THOUSAND) 69
FIGURE 27 EXPORT SCENARIO FOR ULTRASOUND SYSTEMS (HS CODE 901812),
2020–2024 (USD THOUSAND) 70
FIGURE 28 IMPORT SCENARIO FOR MAGNETIC RESONANCE IMAGING SYSTEMS
(HS CODE 901813), 2020–2024 (USD THOUSAND) 71
FIGURE 29 EXPORT SCENARIO FOR MAGNETIC RESONANCE IMAGING SYSTEMS
(HS CODE 901813), 2020–2024 (USD THOUSAND) 72
FIGURE 30 IMPORT SCENARIO FOR X-RAY SYSTEMS (HS CODE 902214),
2020–2024 (USD THOUSAND) 73
FIGURE 31 EXPORT SCENARIO FOR X-RAY SYSTEMS (HS CODE 902214),
2020–2024 (USD THOUSAND) 74
FIGURE 32 VASCULAR IMAGING MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 77
FIGURE 33 INVESTMENT AND FUNDING SCENARIO, 2019–2023 77
FIGURE 34 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 78
FIGURE 35 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 78
FIGURE 36 TOP 10 PATENT APPLICANTS FOR CT SCANNERS,
JANUARY 2015–NOVEMBER 2025 84
FIGURE 37 TOP 10 PATENT APPLICANTS FOR MRI SYSTEMS,
JANUARY 2015–NOVEMBER 2025 85
FIGURE 38 TOP 10 PATENT APPLICANTS FOR ULTRASOUND IMAGING SYSTEMS,
JANUARY 2015– NOVEMBER 2025 86
FIGURE 39 TOP 10 PATENT APPLICANTS FOR X-RAY IMAGING SYSTEMS,
JANUARY 2015– NOVEMBER 2025 87
FIGURE 40 TOP 10 PATENT APPLICANTS FOR NUCLEAR IMAGING SYSTEMS,
JANUARY 2015–DECEMBER 2025 88
FIGURE 41 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 98
FIGURE 42 KEY BUYING CRITERIA, BY END USER 99
FIGURE 43 NORTH AMERICA: VASCULAR IMAGING MARKET SNAPSHOT 130
FIGURE 44 ASIA PACIFIC: VASCULAR IMAGING MARKET SNAPSHOT 151
FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS IN VASCULAR IMAGING MARKET,
2021–2024 (USD BILLION) 184
FIGURE 46 MARKET SHARE ANALYSIS OF KEY PLAYERS IN VASCULAR IMAGING
MARKET, 2024 185
FIGURE 47 RANKING OF KEY PLAYERS IN VASCULAR IMAGING MARKET, 2024 186
FIGURE 48 EV/EBITDA OF KEY VENDORS 187
FIGURE 49 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 187
FIGURE 50 VASCULAR IMAGING MARKET: BRAND/PRODUCT COMPARISON 188
FIGURE 51 VASCULAR IMAGING MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2024 189
FIGURE 52 VASCULAR IMAGING MARKET: COMPANY FOOTPRINT 190
FIGURE 53 VASCULAR IMAGING MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 195
FIGURE 54 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2024) 202
FIGURE 55 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 207
FIGURE 56 FUJIFILM CORPORATION: COMPANY SNAPSHOT (2024) 214
FIGURE 57 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2024) 219
FIGURE 58 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 225
FIGURE 59 UNITED IMAGING HEALTHCARE CO., LTD: COMPANY SNAPSHOT (2024) 227
FIGURE 60 SAMSUNG HEALTHCARE: COMPANY SNAPSHOT (2024) 232
FIGURE 61 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2023) 234
FIGURE 62 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2024) 238
FIGURE 63 KONICA MINOLTA, INC.: COMPANY SNAPSHOT (2024) 242
FIGURE 64 NEUSOFT CORPORATION: COMPANY SNAPSHOT (2024) 244
FIGURE 65 TERUMO CORPORATION: COMPANY SNAPSHOT (2024) 248
FIGURE 66 HOLOGIC, INC.: COMPANY SNAPSHOT (2023) 250
FIGURE 67 BAYER AG: COMPANY SNAPSHOT (2024) 255
FIGURE 68 GUERBET: COMPANY SNAPSHOT (2022) 257